From the bench to the bedside. Galectin-3 immunodetection for improving the preoperative diagnosis of the follicular thyroid nodules.

[1]  M. Miettinen,et al.  Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours , 1996, Virchows Archiv.

[2]  J. Rosai.  Immunohistochemical Markers of Thyroid Tumors Significance and Diagnostic Applications , 2003, Tumori.

[3]  Yoshifumi Yamamoto,et al.  Malignant transformation of thyroid follicular cells by galectin-3. , 2003, Cancer letters.

[4]  M. Papotti,et al.  Methodological considerations regarding the use of galectin-3 expression analysis in preoperative evaluation of thyroid nodules. , 2003, The Journal of clinical endocrinology and metabolism.

[5]  M. Papotti,et al.  Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma. , 2002, European journal of endocrinology.

[6]  A. Nicolini,et al.  Large-Needle Aspiration Biopsy for the Preoperative Selection of Follicular Adenoma Diagnosed by Fine-Needle Aspiration as a Microfollicular Nodule or Suspected Cancer , 2002, American journal of clinical oncology.

[7]  A. Vecchione,et al.  Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions , 2001, The Lancet.

[8]  A. Nicolini,et al.  Large-needle aspiration biopsy for the preoperative selection of palpable thyroid nodules diagnosed by fine-needle aspiration as a microfollicular nodule or suspected cancer. , 2000, American journal of clinical pathology.

[9]  M. P. Martegani,et al.  Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  P. De Giuli,et al.  Galectin-3 is a presurgical marker of human thyroid carcinoma. , 1998, Cancer research.

[11]  A. Nicolini,et al.  Large needle aspiration biopsy for reducing the rate of inadequate cytology on fine needle aspiration specimens from palpable thyroid nodules. , 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  M. Sidawy,et al.  Fine‐needle aspiration of thyroid nodules , 1997, Cancer.

[13]  A. Nicolini,et al.  Needle aspiration techniques in preoperative selection of patients with thyroid nodules: a long-term study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Gibbs,et al.  Pharmaceutical research in molecular oncology , 1994, Cell.

[15]  H. Gharib,et al.  Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. , 1994, Mayo Clinic proceedings.

[16]  A. Carpi,et al.  The combination of aspiration needle biopsy with fine needle aspiration in the preoperative evaluation of breast tumors. , 1993, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  N. Sneige,et al.  Diagnostic pitfalls in thyroid fine‐needle aspiration: A review of 394 cases , 1993, Diagnostic cytopathology.

[18]  H. Gharib,et al.  Fine-Needle Aspiration Biopsy of the Thyroid: An Appraisal , 1993, Annals of Internal Medicine.

[19]  M. Mottolese,et al.  Expression of CAR-3 and TAG-72 macromolecules in normal and transformed endometrium: potential diagnostic application in postmenopausal patients. , 1991, Cancer research.

[20]  C. Núñez,et al.  Fine-needle aspiration and needle biopsy of the thyroid gland. , 1989, Pathology annual.

[21]  R. Oldham.  Biological response modifiers. , 1983, Journal of the National Cancer Institute.

[22]  V. Livolsi.  Clinical-Pathological Evaluation of Thyroid Nodules: Handbook and Atlas , 1980 .

[23]  Biomedicine & Pharmacotherapy , 2022 .